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ABSTRACT  We have previously provided evidence that suggests that exposure of cryostat skin 
sections  to normal  human  serum  (NHS)  results  in the antibody-independent CIq  binding to 
cytoplasmic structures of various cell types, leading to classical complement pathway activation 
as evidenced by cytoplasmic C3 deposition. 
In the present  study, we have employed  immunoelectronmicroscopic  methods to clarify the 
exact  nature  of cytoplasmic  C3  binding structures.  Incubation of cryostat skin sections with 
NHS followed  by peroxidase-labeled  rabbit anti-human  C3 serum  (HRP-R/Hu  C3)  revealed 
that intracytoplasmic binding of C3 occurred  in suprabasal  keratinocytes, melanocytes,  fibro- 
blasts, smooth  muscle  cells,  endothelial  cells,  pericytes,  Schwann cells,  and  nerve axons, but 
not  in  basal keratinocytes,  Langerhans  cells,  and  other cellular  constituents of  the  skin.  C3 
binding, as revealed  by the deposition of  HRP reaction  product, was exclusively confined  to 
intermediate-sized filaments  (ISF), which can therefore be considered to represent  the subcel- 
lular site for classical complement  pathway activation. Under experimental conditions that do 
not allow classical complement  pathway activation, ISF were not decorated. 
Our  observation  that  ISF  of  ontogenetically  different  cell  types  share  the  capacity  of 
complement  fixation is in accordance  with the recent finding that different  ISF types, despite 
their biochemical  and antigenic heterogeneity, have common  alpha-helical  domains and may 
provide a clue  to the  mechanism  and  site  of  interaction  between  complement  components 
and  ISF. 
In a  previous study (18),  we reported that the incubation of 
cryostat sections of normal human skin with normal human 
sera  (NHS)  followed by a  fluorescein-isothiocyanate-labeled 
rabbit-anti human C3 antiserum (FITC-R/Hu C3) results in 
a bright cytoplasmic staining of certain cell populations within 
the  skin.  We have  also presented  evidence  that  cytoplasmic 
deposition of C3 is most likely an antibody-independent phe- 
nomenon that is due to binding of Clq to cytoplasmic structures 
and  subsequent  activation  of the  classical  complement  (C) 
cascade.  Although  the  immunofluorescence  (!F)  procedure 
employed  allowed  us  to  conclude  that  keratinocytes  of the 
upper  epidermal  layers  and  smooth  muscle  cells  within  the 
dermis displayed the C-binding cytoplasmic components, we 
observed a variety of positively stained cells in the dermis and 
epidermis whose exact nature could not be determined by IF. 
Another limitation of the IF technique employed was that it 
did not permit the morphological identification of  the structural 
component  relevant  to  complement  binding.  In  the  present 
study, we report  on immunoelectronmicroscopic studies  that 
show that intermediate-sized filaments (ISF) represent the only 
cytoplasmic substrate upon which C3 deposition occurs. Within 
the epidermis, HRP-reaction product enveloped ISF of supra- 
basal  keratinocytes  and  melanocytes  whereas  ISF  of basal 
keratinocytes  and  of Langerhans  cells  did  not  exhibit  C3- 
binding properties.  Within  the dermis,  C3-binding  ISF were 
identified within fibroblasts, endothelial cells,  smooth muscle 
cells, pericytes, Schwann cells, and nerve axons. 
MATERIALS  AND  METHODS 
Biopsies 
Specimens of normal human skin, obtained from five individuals undergoing 
corrective plastic breast surgery under general anaesthesia, were embedded in 
Tissue-Tek II O.C.T. compound (Lab-Tek Products, Division Miles Laboratories 
Inc.,  Elkhart,  IN),  snap frozen in liquid nitrogen and stored at  -70°C  until 
sectioning. 4-/~m cryostat sections were either immediately incubated with the 
various immunoreactants listed below or, in a few experiments, subjected to an 
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the insoluble ISF network (5, 7, 20, 27, 36, 37, 40). Briefly, sections pretreated 
with or without 0.2% Triton X-100 at 4°C were reacted with a series of low/ 
high/low ionic strength buffers with or without the enzyme inhibitors phenyl- 
methylsulfonylfluoride (1 mM, Sigma Chemical Co., St. Louis, MO) and l-l- 
tosylamide-2-phenylethyl chloromethyl ketone (2 raM, Sigma Chemical Co.), 
washed with PBS and incubated for immunoperoxidase studies (36). 
Sera 
Fresh sera were obtained from 20 healthy individuals and from two patients 
with hereditary C4 deficiency (43). Serum samples were either used immediately 
or stored at -70°C until use. 
Conjugates 
Fluorescein-isothiocyanate (FITC)-labeled rabbit  antisera directed against 
human IgG, IgM, and IgA were purchased from Kent Laboratories Ltd, North 
Vancouver, B.C.. Canada and used at a dilution of l:10. HRP-labeled rabbit 
antisera directed against either human C3 or human Ig were obtained from Dako 
immunoglobulins, Copenhagen, Denmark and used at a 1:20 dilution. 
Immunofluorescence Procedure 
For the detection of circulating antibodies against cytoplasmic antigens of skin 
ceils, cryostat sections of normal human  skin were first incubated with  1:10 
diluted NHS or C4-deficient sera and, after extensive PBS washes, with the 
respective FlTC-labeled  rabbit  anti-human  immunoglobulin sera. Only sera 
devoid of IF-detectable amounts  of antibodies directed against cytoplasmic 
antigens in any skin cell were used in further immunoperoxidase procedures. 
Immunoperoxidase Studies 
4-~m cryostat sections were air-dried for 20 min, washed in PB  S for 10 min, 
and incubated for 30 min at 37°C with a  1:10 dilution of either (a) untreated 
NHS, (b) NHS containing either I0 mM EDTA or EGTA, concentrations known 
to inhibit classical and/or alternate pathway activation or (c) C4-deficient sera; 
in some experiments, PBS was substituted for sera. After three washes in PBS, 
sections were incubated with appropriate dilutions of either HRP-R/Hu C3 or 
HRP-conjugated rabbit anti-human immunoglobulin (HRP-R/Hu  lg) for 30 rain 
at 37°C. After three PBS washes, sections were fixed in half-strength Karnovsky's 
fixative  (23) for 60 min at room temperature and then washed in 0.1 M cacodyiate 
buffer, pH 7.4 at 4°C. For visualization  of the bound immunoreactants, specimens 
were incubated in DAB medium (16) for 20 min at room temperature in the dark 
and then processed for both light and electron microscopic  examination. For light 
microscopic purposes, sections were mounted  with  glycerine:PBS (4:1). For 
electron microscopy, sections that had been extensively washed in 0.1 M caco- 
dylate buffer at 4°C were postfixed in potassium-ferroeyanide  osmium tetroxide 
(24) for 60 rain  on ice. This  postfixation method  enhances the  contrast  of 
membranous structures, reduces the overall density of the cytoplasmic back- 
ground and,  thus, accentuates electron-dense deposits. Specimens were then 
rapidly dehydrated in a graded series of alcohols and embedded in Epon 812. 
After polymerization (24 h, 60°C), the Epon sheet was detached from the slides 
by immersion in liquid nitrogen. Small blocks were excised and remounted using 
Beem (Polaron Equipment Ltd., Watford, England) capsules. In preliminary 
experiments, vertical sectioning had demonstrated the even penetration of the 
antibody-HRP complex through the entire depth of the section. Subsequently, 
horizontal serial sections were cut with a Reichert "Ultraeut" uhramierotome (C. 
Reichen, Optische Werke AG, Vienna, Austria) and stained with lead citrate, 
and approximately every tenth section was examined with a Philips 400 electron 
microscope operating at 80 kV. By doing so, we excluded the possibility that lack 
of penetration might have mimicked negative results in nonreactive areas of the 
specimen. 
RESULTS 
Light Microscopic Findings 
When  cryostat  sections  of  normal  human  skin  were  first 
exposed to NHS, subsequently reacted with a  HRP-labeled R/ 
Hu C3 antiserum, and then incubated for the demonstration of 
HRP activity, a  seemingly homogeneous deposition of brown- 
ish  reaction  product  was  revealed  within  the  cytoplasm  of 
various cell types,  but was not observed on any extracellular 
structure. The staining pattern depicted in Fig.  1 was virtually 
identical for all NHS and substrates tested. HRP-positive cells 
within the basal layer of the epidermis were dendritic in shape 
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and--according to their distribution pattern--were considered 
to be melanocytes.  Residual basal keratinocytes,  i.e.,  the vast 
majority of cells within the basal layer, were devoid of reaction 
product. The lack of C3-binding capacity of basal keratinocytes 
contrasted sharply with the consistent detection of C3-binding 
sites within  suprabasal  keratinocytes.  Although with varying 
intensity, HRP reaction product was detected within essentially 
all suprabasal keratinocytes,  and was  confined to  their cyto- 
plasm, regularly sparing nuclei and intercellular spaces. Within 
the dermis,  cytoplasmic C3-binding was discernible within at 
least  three  distinct  cell  systems.  These  included  endothelial 
cells,  smooth  muscle  cells,  and  a  population  of apparently 
uniform cells with stellate cytoplasmic processes scattered be- 
tween bundles of connective tissue throughout the entire dermis 
that most likely represent fibroblasts. 
An  essentially  identical  staining  pattern  was  seen  when 
cryostat sections had been previously  subjected  to  extraction 
procedures described above, but was not observed when NHS 
was substituted by either C4-deficient sera or PBS, or was used 
in  the  presence  of  10  mM  EGTA  and/or  EDTA  (Fig.  2). 
Similarly,  HRP  reaction  product  was  not  deposited  at  any 
location when HRP-R/Hu  C3 was replaced by HRP-R/Hu  Ig. 
These  results confirm those obtained  in  our  previous immu- 
nofluorescence studies (18). 
Electron Microscopic Findings 
EP1DERMlS:--Light microscopic studies had already shown 
that, within the basal layer of the epidermis,  the only  HRP- 
reactive cells were  dendritic in shape  and displayed  a  distri- 
bution  pattern suggestive  for  melanocytes.  At  the ultrastruc- 
tural level, these C3-binding cells were located directly above 
the basal lamina, frequently protruded in a teardroplike fashion 
towards  the  underlying  dermis  (Fig.  3a),  contained  singly 
dispersed  melanosomes  at  all  stages  of development  within 
their cytoplasm and, thus, were identified as melanocytes (3). 
Within these cells,  HRP  reaction product was deposited con- 
tinuously  along  virtually  all  cytoplasmic  ISF,  but  was  not 
associated with any other cellular  structure nor with the cell 
membrane. These HRP-reactive nonbranching filaments were 
either located mainly in the perikaryon region (not shown) or 
were seen in the dendrites (Fig. 4), as is characteristic for ISF 
within melanocytes (22). The major portion of cells constituting 
the  basal  layer  was  completely  devoid  of reaction  product. 
These  HRP-negative  cells  contained  melanosome-aggregates 
and loosely packed tonofilaments, were attached to the under- 
lying basal lamina via hemidesmosomes and therefore repre- 
sented basal keratinocytes (Figs. 3 a  and 4, reference 3). 
In contrast to HRP-negative basal keratinocytes, the reaction 
product  was  associated  with  tonofilament  bundles of supra- 
basal keratinocytes (Fig.  3  a  and b).  Although tonofilaments 
within  the  cells  of the  spinous  layer  are  tightly packed  and 
appear as electron-dense structures, HRP deposition was easily 
recognized in the majority of these cells in which it enveloped 
the  individual tonofibrils.  However,  the  intensity of staining 
varied in individual cells and in some cells HRP deposits were 
not  unequivocally  demonstrable,  i.e.,  we  were  not  able  to 
decide  whether dark-appearing  tonofibrils were covered  with 
only minute amounts of the tracer or appeared electron-dense 
due to dense packing. 
The epidermis harbors a third distinctive cell population, the 
Langerhans cells (42). These cells are highly dendritic in shape 
and are located at a suprabasal position. Langerhans cells have 
a  convoluted nucleus (Fig. 5 a) and contain unique trilaminar FIGURES  1 and 2  Light  microscopic visualization of cytoplasmic C3-binding sites  in  normal  human  skin: cryostat sections were 
incubated with (Fig. 1) NHS or (Fig. 2) C4-deficient serum and then with HRP-R/Hu C3. Fig. 1: Suprabasal keratinocytes, fibroblasts 
(arrows),  endothelial cells  (arrowheads)  and smooth  muscle cells of  Mm.  arrectores pilorum  (inset)  exhibit strong cytoplasmic 
staining. Within  the basal  layer of the epidermis, cytoplasmic HRP deposition is only seen  within  dendritic cells (melanocytes). 
Cell nuclei and extracellular structures  are devoid of  HRP reactivity. The dermal-epidermal junction  is marked by a dotted line. 
Bars, 10 p.m. Main field x  800, inset x  1,000. Fig. 2: HRP deposition is not seen under conditions that do not allow classical  pathway 
activation. Bgr, 10 #m. x  800. 
cytoplasmic structures termed  Langerhans cell granules (Fig. 
5 b).  10-nm filaments within these cells did not display com- 
plement-binding  properties  as was  evidenced  by a  complete 
HRP-negativity (Fig. 5 b). 
DERMIS:--Deposition of HRP reaction product within the 
dermis  was  confined to  cellular  elements  and  never  seen  in 
association  with  components of the  extracellular  space.  One 
group  of ceils  possessing  C-binding  ISF  was  intermingled 
between  collagen  bundles,  characterized  by  long  and  thin 
cytoplasmic processes (Fig. 3 a) and was therefore identified as 
either active (round nuclei, well-developed rough endoplasmic 
reticulum,  stellate  shape)  or resting  (flattened  nuclei,  scanty 
cytoplasm, spindle shape) fibroblasts.  HRP precipitates enve- 
loped each ISF in a continuous fashion (Fig. 3 c). 
Careful sampling of vascular structures revealed that endo- 
thelial  cells  and  pericytes comprising the  capillary wall  also 
contained  C-binding  ISF  (Fig.  7).  Again, this  was a  regular 
finding  with  all  NHS  and  substrates  tested.  In  cutaneous 
nerves,  HRP  reaction  product  was  deposited  along  10-rim 
filaments within nerve axons, i.e., neurofilaments (Fig. 8 a) and 
along ISF of Schwann cells (not shown). Myelin sheaths did 
not exhibit C-binding capacity, which is in accordance with a 
recent report from Vanguri et al.  (44)  indicating  that central 
nervous system, but not peripheral  nerve myelin leads to the 
activation of the classical complement pathway in the presence 
of fresh serum. 
Another cell  population  exhibiting  C-binding  cytoplasmic 
structures is the smooth muscle cells ofMm. arrectores pilorum. 
Within  these  cells,  HRP  reaction  product was,  at  a  varying 
intensity, only seen in association with filamentous structures, 
but spared the perinuclear portion that characteristically lacks 
cytoskeletal elements.  Smooth muscle fibers contain three dif- 
ferent classes of myofilaments, i.e., actin (~7.5 nm in diameter), 
myosin (~15 nm in diameter), and ISF (~10 nm in diameter), 
which  form  an  interconnected  filamentous  network  linking 
together cytoplasmic dense bodies and membrane-bound dense 
plaques (5). Even in routine electron microscopic specimens it 
is  difficult  to  identify  the  ISF  scattered  in  between  other 
SCHULEr ET At.  Complemenl-bindingon  Cytoplasmic Structures  545 FIGUI~E  3  Immunoelectronmicroscopic visualization of cytoplasmic C3-binding sites in epidermis and papillary dermis of normal 
human skin: cryostat sections were incubated with NHS and then with  HRP-R/Hu  C3. (a) Within  the epidermis, the HRP reaction 
product decorates keratin filament bundles within suprabasal keratinocytes (sbK)  at a varying intensity. In some sbK staining is 
only slight so that it is not readily apparent at this low .magnification. By contrast, basal keratinocytes (bK), which characteristically 
contain numerous melanosome aggreates (arrow) always appear unstained. Melanocytes (AI I  which  protrude into the dermis in 
a teardroplike fashion exhibit intracytoplasmic  HRP-reactivity as do fibroblast processes within  the dermis  (arrowhead). Bar, 4.0 
/Lm. x  3,500.  (b)  Close-up of a basal keratinocyte (bK) neighboring a suprabasal keratinocyte (sbK).  H RP deposits decorate the 
tightly packed keratin filaments of sbK, but spare the loosely arranged keratin filaments of bK. Note cut-off of filament staining at 
the desmosomal attachment plaque of the sbK. N,  nucleus of  sbK, D, desmosomes.  Bar, 0.5/~m.  x  30,000.  (c)  Close-up of  the 
fibroblast process shovqn in a  reveals heavily HRP-deco~ated ISF. Bar, 0.2/Lm. x  47,000. 
546 FiGUrE  4  Immunoelectronmicroscopic  visualization  of  C3-binding  ISF  within  a  melanocyte dendrite.  Melanosomes  (m)  are 
characteristically embedded in the HRP-reactive network of 10-nm filaments; the perinuclear area (*) of this particular melanocyte 
contains  no  ISF  and  thus  lacks  HRP-reaction  product.  A  dotted  line  marks  the  dermal-epidermal junction;  MC,  melanosome 
complexes within a basal keratinocyte. Bar, 0.5 #m. x  30,000. 
FIGURE  5  (a)  Cryostat  sections  of  normal  human  skin  reacted  with  NHS  and  HRP-R/Hu  C3.  The  cytoplasm  of  suprabasal 
keratinocytes (sbK)  contains ISF-associated HRP-deposits at a varying intensity, whereas the cytoplasm of a Langerhans cell (LC) 
appears unstained.  Bar, 2 #m.  x  4,500.  (b)  High  magnification of the Langerhans cell  reveals HRP-negative ISF. Arrow indicates 
characteristic trilaminar tangerhans cell granule. Bar, 0.2 #m. x  45,000. 
filaments. Because the limitations imposed by the requirement 
for lightly stained sections in peroxidase immunocytochemical 
procedures prevent the accurate and separate identification of 
7.5-nm  and  10-nm  filaments  and,  thus,  do  not  allow  the 
unequivocal identification of the strncture(s) upon which HRP 
reaction product is deposited, we employed an extraction pro- 
cedure with low and high salt buffers that solubilizes  actin and 
myosin filaments, leaving a cytoskeleton composed predomi- 
nantly of ISF still attached to dense bodies (5, 20, 36). Using 
this procedure, the staining pattern seen at the light microscopic 
SCHULER fT  AL.  Complement-binding  on Cytoplasmic Structures  547 FIGURE  6  Immunoelectronmicroscopic visualization of C3-binding filaments within a smooth muscle cell. Cryostat sections were 
pretreated with  a series of  low and high  ionic strength buffers  and then reacted with  either NHS  (a)  or C4-deficient serum  (b) 
followed  by  HRP-R/Hu  C3.  (a)  Filaments  remaining  after  the  extraction  procedure are  heavily decorated with  HRP-reaction 
product after the use of NHS. They therefore appear thicker than in the control  (b).  (b)  Filaments remaining after the extraction 
procedure are accentuated by conventional OsO4 postfixation but do not display any HRP reactivity after the use of C4-deficient 
serum.  Filaments have an average diameter of 10 nm and, thus, represent ISF. Bar, 0.2/Lm.  x  75,000. 
FIGURE  7  Immunoelectronmicroscopic visualization of C3-binding sites within capillary endothelium. Cryostat sections of normal 
human skin were incubated with  NHS and then with  HRP-R/Hu C3.  (a)  HRP reaction product is deposited within the cytoplasm 
of endothelial cells (E) and a pericyte (P). Bar, 2 pro. X 3,200. (b) Higher magnification of the endothelial cell reveals ISF enveloped 
by the electron-dense marker.  /_, vascular lumen;  bl,  basal  lamina. Bar, 0.2/Lm.  x  48,000. 
548  THE JOURNAL OF  CELL BIOLOGY. VOLUME 95,  1982 FIGURE  8  Immunoelectronmicroscopic  visualization of  C3-binding  ISF  within  a cutaneous  nerve. Cryostat sections of  normal 
human skin were incubated with either NHS (a) or C4-deficient serum (b) and then with HRP-R/Hu C3. (a) ISF within a myelinated 
axon appear decorated with HRP-reaction product. Bar, 0.2/~m. 
sheath. Bar, 0.2 #m. x  48,000. 
level was indistinguishable from that seen in untreated sections; 
ultrastructurally,  HRP reaction product enveloped all the re- 
maining filamentous structures (Fig. 6 a). Using conventionally 
postftxed (3% aqueous OsO4 followed by 5% veronal-acetate- 
buffered uranyl acetate) control sections, filaments remaining 
after the extraction procedure appeared uniform, had a diam- 
eter of ~10 nm and, thus, represented ISF (Fig. 6 b). 
Similarly, after application of  the extraction procedures listed 
above, an intact insoluble ISF network was left behind in all 
other cell types tested and HRP-reactivity was identical to that 
seen in untreated sections. 
In  addition  to  the  cell  types  listed,  normal  dermis  also 
contains a small number of other cellular constituents such as 
mast  cells,  lymphocytes,  and  histiocytes.  In  the  specimens 
investigated,  the  number  of these  cells  encountered  was  ex- 
tremely small and their preservation not adequate enough to 
draw valid conclusions with regard to their  expression of C- 
binding cytoskeletal structures. 
COr~tROLS:--In all control specimens,  i.e.,  after substitu- 
tion of NHS by PBS, or under conditions that do not allow 
classical and/or alternate pathway activation, HRP deposition 
was not observed (Fig. 2, 6  b,  and 8 b).  This is  also true for 
specimens in which HRP-R/Hu C3 was replaced by HRP-R/ 
Hu Ig. Thus, no evidence was obtained at the electron micro- 
scopic level that autoantibodies participate in the generation of 
C3 deposition along ISF. 
DISCUSSION 
In a  previous study (18),  we found that exposure of cryostat 
sections of normal human skin to fresh NHS and FITC-R/Hu 
C3  resulted  in  a  strong  cytoplasmic fluorescence  of various 
skin cells.  This finding was in accordance with recent reports 
by  Linder et  al.  (28-30,  32)  who first  described  cytoplasmic 
binding  to  certain  mesenchymal cells  in  tissue  sections  and 
culture. For at least two cell types, i.e., suprabasal keratinocytes 
X 48,000. (b) No reaction product is discernible on ISF. my, myelin 
and smooth muscle cells, we presented evidence that cytoplas- 
mic C3 binding was most likely due to an antibody-independ- 
ent binding of Clq to cytoplasmic sites  followed by activation 
of the  classical  C  cascade  (18).  In the  case  of melanocytes, 
fibroblasts, and endothelial cells,  cytoplasmic C3 binding was 
also shown to result from classical C activation. However, with 
regard to these cell types, we could not determine whether this 
binding had occurred in an antibody-independent fashion or 
had been initiated by C-binding anticytoplasmic autoantibod- 
ies;  the  occasional  occurrence  of such  antibodies  has  been 
described (17,  19, 31). The major limitations of our IF studies 
were that the exact nature of certain cells with cytoplasmic C3- 
binding properties could not be determined and, more impor- 
tantly,  that they did not provide a  clue to the morphological 
substrate  of C3  deposition.  In this  report,  we  unequivocally 
demonstrate that suprabasal keratinocytes, melanocytes, fibro- 
blasts,  smooth  muscle  cells,  endothelial  cells,  pericytes, 
Schwann cells,  and nerve axons possess cytoplasmic C3-bind- 
ing structures, whereas basal keratinocytes and epidermal Lan- 
gerhans  cells  do  not.  The  visualization  of cytoplasmic  C3 
binding within the cell types listed was a fmding consistent for 
all  NHS  and  substrates  tested.  This varies  slightly from our 
earlier IF studies in which C3 binding within melanocytes and 
endothelial  ceils  was  only observed  in  some  instances.  The 
reason for this discrepancy may be due to a higher sensitivity 
of the immunoperoxidase technique as compared with conven- 
tional IF (41). 
In addition, our results now provide definitive proof that-- 
under the tissue processing techniques used--ISF represent the 
only  cytoplasmic  structures  upon  which  C3  deposition  can 
occur, as has been proposed by Linder et al.  (30,  32)  on the 
basis of light microscopic studies. However, we cannot exclude 
the possibility that other cellular constituents, e.g., cytoplasmic 
matrix  and  microtubular  structures,  which are  removed and 
disrupted  by freezing, thawing,  and washing procedures (45) 
might also display C-binding properties.  This is also true for 
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to be extracted in order to permit an unequivocal proof for the 
C3-binding  capacity of ISF; in  the other cell types studied, 
actin filaments constitute only a minor portion of the cytoskel- 
eton and,  therefore,  cannot be easily discerned in the lightly 
stained  sections  required  for our  immunoperoxidase  experi- 
ments. 
Together with microtubules and micro  filaments,  ISF com- 
prise the cytoskeleton of higher eukaryotic cells (15, 25). Mor- 
phologically, ISF are defined as unbranched filaments with an 
average diameter of 10 rim; on cross-sections, they may exhibit 
a  hollow core (21).  Despite  their  morphological uniformity, 
ISF display broad differences in size and complexity of their 
constitutive subunit proteins (2, 4, 6, 8-14, 25, 26, 35, 36). 
On both biochemical and immunological grounds, five maj or 
classes  of ISF  can  be  differentiated,  i.e.,  keratin  filaments, 
desmin filaments, vimentin fdaments, neurofilaments, and glial 
filaments  (25).  Linder et  al.  have  provided  suggestive  (light 
microscopic) evidence for the occurrence of C-binding sites on 
filaments  of the  desmin-  and  vimentin-type  (30,  32).  Our 
studies demonstrate that cytoplasmic C3 binding is not con- 
freed to these two ISF types known to occur within melano- 
cytes, fibroblasts,  smooth muscle cells,  endothelial  cells,  and 
Schwann cells  (25),  but can also be detected on keratin  fila- 
ments and neurofilaments. Thus, at least four of the five ISF 
types known so far bear C-binding sites. From our studies, we 
cannot yet draw final conclusions as to the ISF subunit respon- 
sible  for  C3  binding.  Although  extraction  procedures  with 
nonionic detergent  and  low/high ionic salt  buffers excluded 
the possibility that cytoplasmic structural components loosely 
attached to ISF were responsible for the C-binding phenomena 
observed,  these  experiments  did  not  provide  information 
whether this functional property was inherent to filament core 
proteins or, alternatively, to consistently and specifically asso- 
ciated proteins. There exists  evidence that indicate that alpha- 
helical segments,  although displaying significant amino  acid 
sequence variability, comprise the basic framework of ISF and 
that the biochemical and immunological differences reported 
for ISF of different cell types reside within their non-alpha- 
helical regions (4, 39). The recent characterization of a mono- 
clonal antibody that binds to most and perhaps all ISF subunit 
proteins that have previously been defined, supports the con- 
cept that all ISF share common domains (34). Our f'mding that 
ISF  in  cell  types  containing  different  ISF  classes  have  the 
capacity for C3 binding leads us to the assumption that  the 
C3-binding site is also located within subunit domains common 
to most, if not all, ISF subunit proteins, i.e., the alpha-helical 
segment (4, 39). Following this reasoning, the finding that ISF 
of basal keratinocytes and epidermal Langerhans cells do not 
bear C3-binding sites  may be due to different biochemical or 
physicochemical properties of ISF alpha-helical regions within 
these  cells  or,  alternatively,  may  be  due  to  masking  of C- 
binding fdament wall proteins by associated proteins peculiar 
for these cell types. Recently, it has been shown that a class of 
cationic structural proteins, termed fdaggrin, associated specif- 
ically with  ISF in a  stoichiometric manner  that  suggests an 
ionic interaction with the alpha-helical domains of ISF (38). It 
therefore seems conceivable that differences in C-binding ca- 
pacity may reflect  charge  differences  between  alpha-helical 
portions of ISF in different cells or in cells at different stages 
of  differentiation. In this context, it is of  interest that polyanions 
can activate the C system via the classical pathway by binding 
directly to Clq (1, 33). Thus, it does not seem unreasonable to 
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assume  that  C3  deposition  on  ISF  is  initiated  by an  ionic 
interaction between Clq and negatively charged alpha-helical 
portions of ISF. The validity of this concept is currently being 
investigated on isolated ISF. 
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